| FDA's perspectives on cardiovascular devices. | |
| | |
MedLine Citation:
|
PMID: 20559979 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Food and Drug Administration (FDA) decision process for approving or clearing medical devices is often determined by a review of robust clinical data and extensive preclinical testing of the device. The mission statement for the Center for Devices and Radiological Health (CDRH) is to review the information provided by manufacturers so that it can promote and protect the health of the public by ensuring the safety and effectiveness of medical devices deemed appropriate for human use (Food, Drug & Cosmetic Act, Section 903(b)(1, 2(C)), December 31, 2004; accessed December 17, 2008 http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm). For high-risk devices, such as ventricular assist devices (VADs), mechanical heart valves, stents, cardiac resynchronization therapy (CRT) devices, pacemakers, and defibrillators, the determination is based on FDA's review of extensive preclinical bench and animal testing followed by use of the device in a clinical trial in humans. These clinical trials allow the manufacturer to evaluate a device in the intended use population. FDA reviews the data from the clinical trial to determine if the device performed as predicted and the clinical benefits outweigh the risks. This article reviews the regulatory framework for different marketing applications related to cardiovascular devices and describes the process of obtaining approval to study a cardiovascular device in a U.S. clinical trial. |
| | |
Authors:
|
Eric A Chen; Sonna M Patel-Raman; Kathryn O'Callaghan; Matthew G Hillebrenner |
Related Documents
:
|
11010649 - Medical devices; anesthesiology devices; classification of nitric oxide administration ... 18177839 - An auxiliary device for chopsticks operation to improve the food-serving performance. 10179319 - Medical devices; 30-day notices and 135-day pma (premarket approval application) supple... 2653609 - Lapidus: when and why? 10558459 - Foods--adulteration involving hard or sharp foreign objects; compliance policy guide; a... 18677819 - International conference on harmonisation; guidance on q4b evaluation and recommendatio... 6898239 - Trace elements: implications for nursing. 18853299 - An evaluation of the implementation of the cramer classification scheme in the toxtree ... 3180109 - Hypothalamic serotonin: pharmacological, biochemical, and behavioral analyses of its fe... |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-03-10 |
Journal Detail:
|
Title: Journal of cardiovascular translational research Volume: 2 ISSN: 1937-5395 ISO Abbreviation: J Cardiovasc Transl Res Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2010-06-18 Completed Date: 2010-10-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101468585 Medline TA: J Cardiovasc Transl Res Country: United States |
Other Details:
|
Languages: eng Pagination: 143-6 Citation Subset: IM |
Affiliation:
|
Center for Devices and Radiological Health, U.S. Food and Drug Administration, 9200 Corporate Boulevard, HFZ-450 Room 220V, Rockville, MD 20850, USA. eric.chen@fda.hhs.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cardiology / instrumentation*, legislation & jurisprudence Clinical Trials as Topic / legislation & jurisprudence Consumer Product Safety / legislation & jurisprudence Cooperative Behavior Defibrillators, Implantable Device Approval* / legislation & jurisprudence Equipment Design Equipment Safety Evidence-Based Medicine Government Regulation* Guidelines as Topic Health Policy* Heart Valve Prosthesis Heart-Assist Devices Humans Interdisciplinary Communication Pacemaker, Artificial Product Labeling Prosthesis Design Risk Assessment United States |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bone marrow cell therapy after acute myocardial infarction. Back to bench, or ready for an outcome t...
Next Document: Pediatric Cardiac Devices-An FDA Pediatrician's Perspective of the Challenges and Potential Solution...